Albuterol Sulfate Solution
Product Images NDC 64980-642

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 64980-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Percent Incident Of Adverse Reaction (Percent Incident Of Adverse Reaction)

This text provides information about the percent incidence of adverse reactions associated with different body systems such as the central nervous system, gastrointestinal system, ear, nose, and throat, cardiovascular system, and respiratory system. Adverse reactions listed include tremors, dizziness, nervousness, headache, sleeplessness, nausea, dyspepsia, nasal congestion, pharyngitis, tachycardia, hypertension, bronchospasm, cough, bronchitis, and wheezing.*

FDA Label Image

Structure (Structure)

FDA Label Image

Figure 1 (Figure 1)

FDA Label Image

Figure 2 (Figure 2)

FDA Label Image

Figure 3 (Figure 3)

FDA Label Image

Figure 4 (Figure 4)

FDA Label Image

Figure 5 (Figure 5)

This text contains instructions and information about Albuterol Inhalation Solution, USP, including its potency, usage, dilution before use, administration through an inhaler, storage recommendations, precautions, and contact information for customer service. It also mentions the contents of one 0.5 mL unit-of-use vial and the importance of consulting a physician before use.*

FDA Label Image

Figure 6 (Figure 6)

FDA Label Image

Figure 7 (Figure 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.